Wells Fargo & Company Agios Pharmaceuticals, Inc. Put Options Transaction History

Wells Fargo & Company

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 10, 2024	SELL	$21.32 - $34.81 $820,820 - $1.34 Million	-38,500 Reduced 32.6%	79,600 $2.33 Million
Q3 2023 Nov 13, 2023	SELL	$24.36 - $28.18 $38,976 - $45,088	-1,600 Reduced 1.34%	118,100 $2.92 Million
Q1 2023 May 12, 2023	BUY	$21.74 - $30.93 $2.6 Million - $3.7 Million	119,700 New	119,700 $2.75 Million

226

56.3M

275K

251K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.44B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.